We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

ImClone Motion Denied In Erbitux Case

Law360 (July 31, 2006, 12:00 AM EDT) -- A federal judge on Friday dismissed ImClone Systems Inc.’s motion for summary judgment, thus setting the stage for a trial in an ongoing patent infringement battle over the cancer drug Erbitux....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.